Most users report initial effects like increased energy within the first one to two weeks
Current evidence involving 5-Amino-1MQ and NNMT inhibition is predominantly preclinical
While Semaglutide GLP-1s weight-reducing effects are promising, its crucial to remember that it may also have side effects, such as nausea, diarrhea, and constipation
Do I need to diet while using AOD-9604
Serious side effects are very rare
Neelakantan and colleagues (Biochem Pharmacol, 2017) then took the pharmacological step, reporting that selective, membrane-permeable small-molecule NNMT inhibitors reversed high-fat-diet-induced obesity in mice this is the study most directly relevant to the 5-Amino-1MQ class, because it moves from the target matters to a drug against the target does something in a live animal. And again, it is a mouse study